atropine has been researched along with oleanolic acid in 3 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (oleanolic acid) | Trials (oleanolic acid) | Recent Studies (post-2010) (oleanolic acid) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 4,169 | 31 | 2,404 |
Protein | Taxonomy | atropine (IC50) | oleanolic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.045 | |
Phospholipase A2 | Homo sapiens (human) | 3 | |
DNA polymerase beta | Homo sapiens (human) | 6.8667 | |
DNA polymerase beta | Rattus norvegicus (Norway rat) | 5.6 | |
Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | 1 | |
Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | 3.065 | |
Tissue factor | Homo sapiens (human) | 0.005 | |
Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 4.38 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.8444 | |
Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 | |
Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.065 | |
M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.98 | |
Dual specificity protein phosphatase 3 | Homo sapiens (human) | 5.4 | |
Transcription factor p65 | Homo sapiens (human) | 2.4 | |
Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.065 | |
Protease | Human immunodeficiency virus 1 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bohlin, L; Huss, U; Perera, P; Ringbom, T; Vasänge, M | 1 |
Alvarado-Castillo, C; Cardozo, A; Estrada, O; Fernández, AZ; González-Guzmán, JM; Salazar-Bookaman, M | 1 |
Chłopecka, M; Dziekan, N; Karlik, W; Mendel, M; Wiechetek, M | 1 |
3 other study(ies) available for atropine and oleanolic acid
Article | Year |
---|---|
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
Topics: Acrolein; Alkaloids; Animals; Anthraquinones; Aspirin; Biological Assay; Catalysis; Cinnamomum zeylanicum; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Eugenol; Flavonoids; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Kinetics; Lactones; Models, Molecular; Nitrobenzenes; Oleanolic Acid; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Steroids; Sulfonamides; Sulfones; Syzygium; Terpenes; Triterpenes; Ursolic Acid | 2002 |
Pomolic acid of Licania pittieri elicits endothelium-dependent relaxation in rat aortic rings.
Topics: Animals; Antihypertensive Agents; Aorta; Apyrase; Atropine; Chrysobalanaceae; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Indomethacin; Male; Norepinephrine; Oleanolic Acid; Phytotherapy; Plant Extracts; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Muscarinic; Receptors, Purinergic; Signal Transduction; Vasoconstriction; Vasodilator Agents | 2011 |
Participation of cholinergic pathways in α-hederin-induced contraction of rat isolated stomach strips.
Topics: Acetylcholine; Animals; Araliaceae; Atropine; Cholinergic Agents; Hexamethonium; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Nicotinic Antagonists; Oleanolic Acid; Plant Extracts; Plant Leaves; Rats; Rats, Wistar; Receptors, Muscarinic; Receptors, Nicotinic; Reference Values; Saponins; Signal Transduction; Stomach | 2012 |